{
    "nct_id": "NCT03023631",
    "official_title": "Human Papillomavirus Antibody Response After GARDASIL 9 Vaccination in Patients After Allogeneic Stem Cell Transplantation",
    "inclusion_criteria": "* All English-speaking adult MD Anderson patients with hematologic malignancy at 6-12 months +/- 8 weeks post allogeneic stem cell transplantation who will receive usual post-stem cell transplant vaccinations\n* All patients from approved protocol 2015-0795 will be invited to this vaccine study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior allogeneic SCT\n* Platelet count less than or equal to 25,000 K/uL\n* Absolute neutrophil count less than or equal to 500/uL\n* Patients who have ever received HPV vaccination (at least one dose of HPV vaccine)\n* Patients with a prior history of HPV-related malignancy\n* Female patients who tested positive for pregnancy during pre-SCT evaluation",
    "miscellaneous_criteria": ""
}